News Articles Tagged: Non-myelosuppressive

The Role of Pacritinib in Managing Thrombocytopenia in Myelofibrosis Patients

Focuses on how Pacritinib's non-myelosuppressive properties offer a critical advantage for myelofibrosis patients experiencing low platelet counts.

Pacritinib's Unique Mechanism: A Step Forward in JAK Inhibitor Therapy

Explore how Pacritinib's distinct JAK2/FLT3 inhibition and non-myelosuppressive profile differentiate it in the landscape of myelofibrosis treatments.